Zura Bio Limited (US:ZURA) — Company Overview, News & Financial Data
Zura Bio is a clinical-stage biotech company developing novel medicines for immune and inflammatory disorders.
About Zura Bio Limited
Zura Bio (NASDAQ:ZURA) is a clinical-stage biotechnology company focused on developing innovative medicines for immune and inflammatory disorders. They currently have three assets in Phase 2 ready stage, targeting conditions like systemic sclerosis and other unmet medical needs. With a focus on novel therapies like tibulizumab (ZB-106) and torudokimab (ZB-880), Zura Bio aims to demonstrate their efficacy, safety, and dosing convenience. Despite a potentially overvalued stock, their strong balance sheet suggests they have the resources to advance their pipeline and potentially revolutionize treatment options for patients with these challenging conditions.
Snapshot
Operations
Produtos e/ou serviços de Zura Bio Limited
- Drug Pipeline: This is the core of Zura Bio's activity. It likely consists of several drug candidates in various stages of development, targeting specific immune and inflammatory disorders.
- Lead Candidates: Zura Bio might have 2-3 drug candidates in the most advanced stages (potentially Phase 2 ready), like tibulizumab (ZB-106) and torudokimab (ZB-880).
- Technology Platform: They might have a proprietary technology platform for developing novel immunotherapies or other treatments relevant to their focus area.
- Intellectual Property: Patents and other intellectual property would be crucial to protect their discoveries and potential commercialization of successful drugs.
- Research Partnerships: Collaborations with academic institutions or other companies might be part of their strategy to accelerate drug development.
- Investor Relations: Publicly traded companies like Zura Bio need to maintain investor relations activities to raise capital and keep investors informed about their progress.
equipe executiva do Zura Bio Limited
- Dr. Sandeep C. Kulkarni M.D.CEO & Director
- Dr. Someit Sidhu M.D.Founder & Director
- Ms. Kimberly Ann Davis J.D.COO, Chief Legal Officer & Corporate Secretary
- Dr. Kiran Nistala MBBS, Ph.D.Chief Medical Officer & Head of Development
- Mr. Eric HyllengrenChief Financial Officer
- Dr. Gary Whale Ph.D.Chief Technology Officer
- Ms. Theresa LowryChief Human Resources Officer